8.91 USD
▼-1.23-12.13%
盘后 8.78 -1.46%
2026-09-15
市值
$420.46M
市盈率
—
EPS
-3.21
股息率
—
52 周区间
2.22 – 14.53
成交量
584.55K
Beta
2.20
目标价
35.80
52W 低 2.2252W 高 14.53
价格走势
公司简介
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/mic...